RISK6, a universal 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Adam Penn-Nicholson, View ORCID ProfileStanley Kimbung Mbandi, Ethan Thompson, View ORCID ProfileSimon C. Mendelsohn, Sara Suliman, View ORCID ProfileNovel N. Chegou, Stephanus T. Malherbe, Fatoumatta Darboe, Mzwandile Erasmus, Willem A. Hanekom, Nicole Bilek, Michelle Fisher, Stefan H. E. Kaufmann, Jill Winter, Melissa Murphy, Robin Wood, Carl Morrow, Ildiko Van Rhijn, Branch Moody, Megan Murray, Bruno B. Andrade, Timothy R. Sterling, Jayne Sutherland, Kogieleum Naidoo, Nesri Padayatchi, Gerhard Walzl, Mark Hatherill, Daniel Zak, View ORCID ProfileThomas J. Scriba, the Adolescent Cohort Study team, GC6-74 Consortium, The ScreenTB and AE-TBC teams, CAPRISA IMPRESS team, RePORT Brazil Consortium, Peruvian Household Contacts Cohort study group
doi: https://doi.org/10.1101/19006197
Adam Penn-Nicholson
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Stanley Kimbung Mbandi
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Ethan Thompson
2Center for Infectious Disease Research, Seattle, WA, USA
Simon C. Mendelsohn
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Sara Suliman
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
3Brigham and Women’s Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA
Novel N. Chegou
4DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Stephanus T. Malherbe
4DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Fatoumatta Darboe
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Mzwandile Erasmus
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Willem A. Hanekom
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Nicole Bilek
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Michelle Fisher
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Stefan H. E. Kaufmann
5Max Planck Institute for Infection Biology, Berlin, Germany
6Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA
Jill Winter
7Catalysis Foundation for Health, San Ramon, CA, USA
Melissa Murphy
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Robin Wood
8Desmond Tutu HIV Centre, and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa
Carl Morrow
8Desmond Tutu HIV Centre, and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa
Ildiko Van Rhijn
3Brigham and Women’s Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA
Branch Moody
3Brigham and Women’s Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA
Megan Murray
9Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Bruno B. Andrade
10Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
Timothy R. Sterling
11Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, USA
Jayne Sutherland
12Vaccines and Immunity, Medical Research Council Unit, Fajara, the Gambia
Kogieleum Naidoo
13Centre for the AIDS Programme of Research in Africa, Durban, South Africa
14South African Medical Research Council-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa
Nesri Padayatchi
13Centre for the AIDS Programme of Research in Africa, Durban, South Africa
14South African Medical Research Council-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa
Gerhard Walzl
4DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Mark Hatherill
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Daniel Zak
2Center for Infectious Disease Research, Seattle, WA, USA
Thomas J. Scriba
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
Data Availability
The RISK6 scores and associated clinical data for all cohorts are in Supplementary Tables 5-13.
Posted September 09, 2019.
RISK6, a universal 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Adam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, Simon C. Mendelsohn, Sara Suliman, Novel N. Chegou, Stephanus T. Malherbe, Fatoumatta Darboe, Mzwandile Erasmus, Willem A. Hanekom, Nicole Bilek, Michelle Fisher, Stefan H. E. Kaufmann, Jill Winter, Melissa Murphy, Robin Wood, Carl Morrow, Ildiko Van Rhijn, Branch Moody, Megan Murray, Bruno B. Andrade, Timothy R. Sterling, Jayne Sutherland, Kogieleum Naidoo, Nesri Padayatchi, Gerhard Walzl, Mark Hatherill, Daniel Zak, Thomas J. Scriba, the Adolescent Cohort Study team, GC6-74 Consortium, The ScreenTB and AE-TBC teams, CAPRISA IMPRESS team, RePORT Brazil Consortium, Peruvian Household Contacts Cohort study group
medRxiv 19006197; doi: https://doi.org/10.1101/19006197
RISK6, a universal 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Adam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, Simon C. Mendelsohn, Sara Suliman, Novel N. Chegou, Stephanus T. Malherbe, Fatoumatta Darboe, Mzwandile Erasmus, Willem A. Hanekom, Nicole Bilek, Michelle Fisher, Stefan H. E. Kaufmann, Jill Winter, Melissa Murphy, Robin Wood, Carl Morrow, Ildiko Van Rhijn, Branch Moody, Megan Murray, Bruno B. Andrade, Timothy R. Sterling, Jayne Sutherland, Kogieleum Naidoo, Nesri Padayatchi, Gerhard Walzl, Mark Hatherill, Daniel Zak, Thomas J. Scriba, the Adolescent Cohort Study team, GC6-74 Consortium, The ScreenTB and AE-TBC teams, CAPRISA IMPRESS team, RePORT Brazil Consortium, Peruvian Household Contacts Cohort study group
medRxiv 19006197; doi: https://doi.org/10.1101/19006197
Subject Area
Subject Areas
- Addiction Medicine (335)
- Allergy and Immunology (658)
- Anesthesia (177)
- Cardiovascular Medicine (2565)
- Dermatology (217)
- Emergency Medicine (389)
- Epidemiology (12071)
- Forensic Medicine (10)
- Gastroenterology (741)
- Genetic and Genomic Medicine (3983)
- Geriatric Medicine (375)
- Health Economics (666)
- Health Informatics (2572)
- Health Policy (992)
- Hematology (357)
- HIV/AIDS (824)
- Medical Education (394)
- Medical Ethics (106)
- Nephrology (422)
- Neurology (3747)
- Nursing (206)
- Nutrition (558)
- Oncology (1948)
- Ophthalmology (565)
- Orthopedics (233)
- Otolaryngology (300)
- Pain Medicine (246)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1088)
- Primary Care Research (442)
- Public and Global Health (6411)
- Radiology and Imaging (1354)
- Respiratory Medicine (857)
- Rheumatology (394)
- Sports Medicine (336)
- Surgery (431)
- Toxicology (51)
- Transplantation (184)
- Urology (162)